Pathogen-reduced platelets for the prevention of bleeding (protocol)
This is the protocol for a review and there is no abstract. The objectives are as follows:To determine the effectiveness and safety of pathogen-reduced platelets for the prevention of bleeding in all patients requiring platelet transfusion(s).
Príomhchruthaitheoirí: | Butler, C, Doree, C, Estcourt, L, Stanworth, S, Brunskill, S, Hopewell, S, Murphy, M |
---|---|
Formáid: | Journal article |
Foilsithe / Cruthaithe: |
2011
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Pathogen-reduced platelets for the prevention of bleeding.
de réir: Butler, C, et al.
Foilsithe / Cruthaithe: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (Review)
de réir: Butler, C, et al.
Foilsithe / Cruthaithe: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (Review)
de réir: Estcourt, L, et al.
Foilsithe / Cruthaithe: (2017) -
Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
de réir: Wardrop, D, et al.
Foilsithe / Cruthaithe: (2016) -
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
de réir: Estcourt, L, et al.
Foilsithe / Cruthaithe: (2016)